A phase II study alternating erlotinib with second-line mFOLFOX6 or FOLFIRI for metastatic colorectal cancer

MR Kearney, EY Chen, GM Vaccaro… - Anticancer …, 2019 - ar.iiarjournals.org
… chemotherapy of either oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) or irinotecan, …
in metastatic colorectal cancer than erlotinib and gefitinib, as recently a pre-clinical study also …

The oncology biomarker discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer

AJ Ohnmacht, A Stahler, S Stintzing, DP Modest… - Nature …, 2023 - nature.com
… in combination with 5-fluorouracil, folinic acid and irinotecan (… with 5-fluorouracil, oxaliplatin,
leucovorin and irinotecan (… ADJUVANT clinical trial (“Methods”), which explored gefitinib in …

Radiomics response signature for identification of metastatic colorectal cancer sensitive to therapies targeting EGFR pathway

L Dercle, L Lu, LH Schwartz, M Qian… - … the National Cancer …, 2020 - academic.oup.com
patients treated with cetuximab in combination with FOLFIRI (irinotecan, 5-fluorouracil, and
leucovorin… We retrospectively analyzed one clinical trial involving two treatment arms and 667 …

Nephrotoxicity as a complication of chemotherapy and immunotherapy in the treatment of colorectal cancer, melanoma and non-small cell lung cancer

J Jagieła, P Bartnicki, J Rysz - International Journal of Molecular Sciences, 2021 - mdpi.com
… FOLFIRI regimen (leucovorin, fluorouracil and irinotecan) and … a day) or 5-fluorouracil (425
mg/m 2 ) with leucovorin (20 mg/… assessing the effectiveness and safety of gefitinib (250 mg) …

A review on emerging targeted therapies for the management of metastatic colorectal cancers

R Deshmukh, M Prajapati, RK Harwansh - Medical Oncology, 2023 - Springer
… efficacy against colorectal cancer was 5-fluorouracil [11]. … with bolus 5-FU (irinotecan, bolus
5-FU, and leucovorin [IFL]), … The most significant inhibitors of EGRF are erlotinib and gefitinib (…

ABCG2 protein levels and association to response to first-line irinotecan-based therapy for patients with metastatic colorectal cancer

JA Palshof, CN Cederbye, EVS Høgdall… - International Journal of …, 2020 - mdpi.com
… a combination of 5-fluorouracil/leucovorin (5-FU/LV) and irinotecan. Thirteen (12%) received
phase II study enrolling mCRC patients with acquired irinotecan resistance (the patients

Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapy

H Hirano, K Kato - Japanese journal of clinical oncology, 2019 - academic.oup.com
… Cisplatin and 5-fluorouracil have been considered standard … Negative results from Phase
3 trials testing gefitinib and … Combinations of irinotecan with other cytotoxic agents were …

… , inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer

DJ Propper, F Gao, MP Saunders, D Sarker… - … journal of cancer, 2023 - nature.com
Gefitinib induces a cell cycle arrest in G1 phase with chronic administration and … S phase
such as irinotecan. For example, in a preclinical study in breast cancer of the effects of gefitinib, …

[HTML][HTML] Lost in translation: Revisiting the use of tyrosine kinase inhibitors in colorectal cancer

KK Iyer, NP van Erp, DVF Tauriello… - Cancer Treatment …, 2022 - Elsevier
gefitinib EGFR exon 19 deletion or exon 21 point mutation … CORRECT trial - a randomized
phase III study in patients with … Another issue arose when irinotecan or its active metabolite SN…

[PDF][PDF] Oxaliplatin-induced pulmonary toxicity: a rare but serious complication

KH Suthar, S Al Mutar, R Venkatesan - Cureus, 2020 - cureus.com
… of oxaliplatin with leucovorin and 5-fluorouracil showed a less … agents such as gefitinib,
bleomycin, and mitomycin [14]. In the … or FOLFIRI (5-fluorouracil, leucovorin, and irinotecan) and …